Efficacy and tolerance of a combination of tenofovir disoproxil fumarate plus emtricitabine in patients with chronic hepatitis B: A European multicenter study

2011 ◽  
Vol 92 (1) ◽  
pp. 90-95 ◽  
Author(s):  
Si-Nafa Si-Ahmed ◽  
Pierre Pradat ◽  
Roeland Zoutendijk ◽  
Maria Buti ◽  
Vincent Mallet ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Multicenter Study ◽  
Tenofovir Disoproxil Fumarate ◽  
European Multicenter Study

Correction: DARING-B: discontinuation of effective entecavir or tenofovir disoproxil fumarate long‑term therapy before HBsAg loss in non-cirrhotic HBeAg‑negative chronic hepatitis B

2018 ◽  
Vol 23 (8) ◽  
pp. 711
Author(s):  
George V Papatheodoridis ◽  
Eirini I Rigopoulou ◽  
Margarita Papatheodoridi ◽  
Kalliopi Zachou ◽  
Vassilios Xourafas ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Tenofovir Disoproxil Fumarate ◽  
Term Therapy ◽  
Hbsag Loss ◽  
Long Term Therapy ◽  
Negative Chronic Hepatitis
Sign in / Sign up

Export Citation Format

Share Document